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Tether before synapse
C
hemokines are captured on the surface 
of dendritic cells in lymph nodes, and 
they in turn capture T cells, say Rachel 
Friedman, Jordan Jacobelli, and Matthew 
Krummel (University of California, San Fran-
cisco, CA). The tethered T cells continue to 
search for a site worthy of a full immunological 
synapse, which they can form with either the 
same or another antigen-presenting cell (APC).
Chemokines were known to costimulate T 
cell activation in vitro and up-regulate integrins 
that might slow down the T cells. But chemo-
kines in solution also induced T cell migration 
past a surface laden with stimulatory T cell re-
ceptors (TCRs).
This “paradox,” says Krummel, is resolved 
by the new data. He thinks the T cells bind 
APCs and then move arm over arm, “like 
swinging on monkey bars.” The San Francisco 
group found that T cells contacted, crawled 
along, and then attempted to crawl away from 
chemokine-laden APCs. For some time, how-
ever, they remained tethered to the APC due to 
chemokine-induced signaling in the T cell.
The leading edge of these tethered cells project-
ed out in search of an APC surface and was faster at 
forming an immunological synapse than if chemo-
kine stimulation had never happened. The mecha-
nism behind this improvement is unknown, but 
polarization of the T cell is probably involved, and 
the mechanism worked even if the eventual target 
APC did not itself have bound chemokines.
“You used to think T cells were drawn into a 
cavity and once there they had to fend for them-
selves,” says Krummel. The new results “accen-
tuate the idea of the microenvironment” in which 
T cell movements are tightly choreographed 
within the lymph node.
Reference: Friedman, R.S., et al. 2006. Nat. Immunol. 
7:1101–1108.
Keeping valves clear
H
eart valves achieve an impressive balancing act—they block large 
vessels but only temporarily. The blockage becomes more perma-
nent in rheumatic valvular heart disease (VHD) when tiny, new 
blood vessels clog the valve. Now, Masatoyo Yoshioka, Keiichi Fukuda 
(Keio University, Tokyo, Japan), and colleagues fi  nd that the antiangiogenic 
chondromodulin-I (Chm-I) normally keeps heart valves clear of new blood 
vessels, and its loss is associated with VHD.
The fi  nding was waiting to be made, says Fukuda, because “nobody 
was interested in studying this. Valvular heart disease is common, but 
most cardiologists think this is a disease for cardiac surgeons, and the 
surgeons only do operations.”
Chm-I was already known as 
an antiangiogenic factor in avas-
cular tissues of the eye and carti-
lage. The Tokyo group found that 
it was expressed in heart valves, 
and its deletion led to valves that 
were double the normal size and 
with almost 14-fold more capillar-
ies. A similar pattern of Chm-I loss 
and new vessel growth was seen in mouse models of VHD and atherosclerosis.
Mesenchymal cells from normal valves secreted Chm-I in vitro, and both 
this Chm-I and recombinant Chm-I had antiangiogenic activity. Valves may 
need constant protection against angiogenesis because they are under mechani-
cal stress that could easily initiate the formation of new blood vessels. In some 
individuals this stress may compromise the mesenchymal cells, and thus begin 
the disease process that Fukuda hopes to combat with exogenous Chm-I.
Reference: Yoshioka, M., et al. 2006. Nat. Med. doi:10.1038/nm1476.
Fixing the hole
M
any bacteria attack cells using pore-forming toxins. An efﬂ  ux of 
K+ through these pores activates lipid synthesis that helps the 
cells survive, say Laure Gurcel, F. Gisou van der Goot (University 
of Geneva, Switzerland), and colleagues.
The group’s ﬁ  rst clue was that treatment of cells with aerolysin, a 
pore-forming protein from Aeromonas, triggered processing of SREBP-2. 
Processed SREBP-2 enters the nucleus and induces transcription; its target 
genes turn on cholesterol and fatty acid biosynthesis.
After testing many candidates for the source of the signal, the research-
ers added aerolysin in the presence of high K+ medium. With K+ efﬂ  ux 
prevented, the cells did not activate SREBP-2 and died in droves. A K+ 
ionophore, by contrast, was sufﬁ  cient to induce SREBP-2 activation.
The pathway that emerged leads from K+ entry to assembly of two 
so-called inﬂ   ammasome complexes. These allow autoproteolysis of cas-
pase-1, leading eventually to the activating proteolysis of SREBP-2, and the 
induction of SREBP-2 targets such as fatty acid synthase. All these steps 
were needed to promote cell survival after aerolysin treatment.
The function of the lipid synthesis is uncertain, but a simple plugging of 
the hole is almost certainly not happening. “The pore we are looking at is ex-
tremely stable,” says van der Goot. “It’s not the surface occupied by the holes 
that requires synthesis.” Instead, repair may involve endocytosis or vesiculation. 
Either one may require lipid synthesis to drive or replenish the process.
Reference: Gurcel, L., et al. 2006. Cell. 126:1135–1145.
A heart valve lacking Chm-I ﬁ  lls with 
vascularized muck.
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A T cell (arrow) touches, crawls along, and adheres 
to an APC with surface-bound chemokines (clockwise, 
from top-left).
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